Frédéric Baribaud
Bristol-Myers Squibb (Germany)(DE)Bristol-Myers Squibb (United States)(US)Bristol-Myers Squibb (Belgium)(BE)
Publications by Year
Research Areas
Asthma and respiratory diseases, HIV Research and Treatment, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, IL-33, ST2, and ILC Pathways
Most-Cited Works
- → Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease(2017)772 cited
- → Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis(2009)403 cited
- → Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR(2003)379 cited
- → Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer(2006)375 cited
- → DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells(2002)371 cited
- → DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans(2001)328 cited